Position in GILD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$132,667,278
+$37,391,704 QoQ
Shares Held
951,907
+22.6% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NATIXIS ADVISORS, LLC holds $2,890,133,285 across 14 Drug Manufacturers - General names. GILD ranks #8 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
780,730 | $718,092,031 | |
| 2 | JNJ |
Johnson & Johnson
|
1,744,076 | $426,321,937 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,970,290 | $357,296,184 | |
| 4 | NVS |
Novartis AG
|
2,236,156 | $341,572,828 | |
| 5 | ABBV |
AbbVie Inc.
|
1,313,168 | $285,600,908 | |
| 6 | AZN |
Astrazeneca PLC
|
1,312,499 | $258,851,052 | |
| 7 | AMGN |
Amgen Inc
|
392,002 | $137,925,903 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
951,907 | $132,667,278 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $132,667,278 | 951,907 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $95,275,574 | 776,239 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $71,749,956 | 646,396 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $69,700,753 | 628,671 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $56,045,505 | 500,183 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $30,919,656 | 334,737 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $14,199,393 | 169,363 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $9,842,173 | 143,451 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 | $13,143,906 | 179,439 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $22,652,016 | 279,620 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $18,203,600 | 242,909 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $18,881,456 | 244,991 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $21,124,244 | 254,601 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $16,750,365 | 195,112 | Shares | Defined | 2023-01-27 | |
| 2022-09-30 | $9,832,584 | 159,387 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,433,727 | 136,446 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,062,931 | 68,342 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $12,055,510 | 166,031 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $9,898,233 | 141,707 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,507,293 | 138,067 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $7,135,733 | 110,409 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $5,002,145 | 85,859 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,432,742 | 101,800 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $12,983,163 | 168,744 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $14,012,416 | 187,432 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||